Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis
MetadataShow full item record
CitationCore, Amanda B., Susanna Canali, and Jodie L. Babitt. 2014. “Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis.” Frontiers in Pharmacology 5 (1): 104. doi:10.3389/fphar.2014.00104. http://dx.doi.org/10.3389/fphar.2014.00104.
AbstractMutations in hemojuvelin (HJV) are the most common cause of the juvenile-onset form of the iron overload disorder hereditary hemochromatosis. The discovery that HJV functions as a co-receptor for the bone morphogenetic protein (BMP) family of signaling molecules helped to identify this signaling pathway as a central regulator of the key iron hormone hepcidin in the control of systemic iron homeostasis. This review highlights recent work uncovering the mechanism of action of HJV and the BMP-SMAD signaling pathway in regulating hepcidin expression in the liver, as well as additional studies investigating possible extra-hepatic functions of HJV. This review also explores the interaction between HJV, the BMP-SMAD signaling pathway and other regulators of hepcidin expression in systemic iron balance.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12406967
- HMS Scholarly Articles